APO Research
Talk to an analyst

APO RESEARCH · REPORT

Human Factor VIII Concentrate

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Human Factor VIII Concentrate Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025192 pages

Choose your research edition.

Industry ResearchHuman Factor VIII Concentrate Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Factor VIII Concentrate Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Human Factor VIII Concentrate Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Factor VIII Concentrate Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Factor VIII Concentrate Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Human Factor VIII Concentrate market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Human Factor VIII Concentrate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Human Factor VIII Concentrate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Human Factor VIII Concentrate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Human Factor VIII Concentrate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Human Factor VIII Concentrate include Shandong Taibang Biological Products, Shanghai Xinxing Medicine, Shanghai Raas Corp, Novo Nordisk A/S, Grifols, Pfizer, Hualan Biological, Bayer and SinoCell Tech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Human Factor VIII Concentrate market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Human Factor VIII Concentrate and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Human Factor VIII Concentrate sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Human Factor VIII Concentrate market size, projected growth trends, production technologies, key applications, and end-use industries.

Human Factor VIII Concentrate Segment by Company

Shandong Taibang Biological Products

Shanghai Xinxing Medicine

Shanghai Raas Corp

Novo Nordisk A/S

Grifols

Pfizer

Hualan Biological

Bayer

SinoCell Tech

Shire (Baxter)

Octapharma

NovoNordisk

GC Pharma

CSL

Biogen

Human Factor VIII Concentrate Segment by Type

Blood Extraction

Recombine

Human Factor VIII Concentrate Segment by Application

Von Willebrand's Disease

Congenital Coagulation Factor VIII Deficiency

Acquired Factor VIII Deficiency

Human Factor VIII Concentrate Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Factor VIII Concentrate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Factor VIII Concentrate and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Factor VIII Concentrate.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Human Factor VIII Concentrate market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Human Factor VIII Concentrate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Human Factor VIII Concentrate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Human Factor VIII Concentrate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Human Factor VIII Concentrate Industry Trends Table 2. Human Factor VIII Concentrate Industry Drivers Table 3. Human Factor VIII Concentrate Industry Opportunities and Challenges Table 4. Human Factor VIII Concentrate Industry Restraints Table 5. Global Human Factor VIII Concentrate Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Human Factor VIII Concentrate Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Human Factor VIII Concentrate Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Human Factor VIII Concentrate Sales Market Share by Manufacturers Table 9. Global Human Factor VIII Concentrate Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Human Factor VIII Concentrate Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Human Factor VIII Concentrate Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Human Factor VIII Concentrate Manufacturers, Product Type & Application Table 13. Global Human Factor VIII Concentrate Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Human Factor VIII Concentrate by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Blood Extraction Table 17. Major Manufacturers of Recombine Table 18. Global Human Factor VIII Concentrate Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Human Factor VIII Concentrate Sales by Type (2021-2026) & (k units) Table 20. Global Human Factor VIII Concentrate Sales by Type (2027-2032) & (k units) Table 21. Global Human Factor VIII Concentrate Sales Market Share by Type (2021-2026) Table 22. Global Human Factor VIII Concentrate Sales Market Share by Type (2027-2032) Table 23. Global Human Factor VIII Concentrate Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Human Factor VIII Concentrate Revenue by Type (2021-2026) & (k units) Table 25. Global Human Factor VIII Concentrate Revenue by Type (2027-2032) & (k units) Table 26. Global Human Factor VIII Concentrate Revenue Market Share by Type (2021-2026) Table 27. Global Human Factor VIII Concentrate Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Von Willebrand's Disease Table 29. Major Manufacturers of Congenital Coagulation Factor VIII Deficiency Table 30. Major Manufacturers of Acquired Factor VIII Deficiency Table 31. Global Human Factor VIII Concentrate Sales by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Human Factor VIII Concentrate Sales by Application (2021-2026) & (k units) Table 33. Global Human Factor VIII Concentrate Sales by Application (2027-2032) & (k units) Table 34. Global Human Factor VIII Concentrate Sales Market Share by Application (2021-2026) Table 35. Global Human Factor VIII Concentrate Sales Market Share by Application (2027-2032) Table 36. Global Human Factor VIII Concentrate Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Human Factor VIII Concentrate Revenue by Application (2021-2026) & (k units) Table 38. Global Human Factor VIII Concentrate Revenue by Application (2027-2032) & (k units) Table 39. Global Human Factor VIII Concentrate Revenue Market Share by Application (2021-2026) Table 40. Global Human Factor VIII Concentrate Revenue Market Share by Application (2027-2032) Table 41. Global Human Factor VIII Concentrate Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Human Factor VIII Concentrate Sales by Region (2021-2026) & (k units) Table 43. Global Human Factor VIII Concentrate Sales Market Share by Region (2021-2026) Table 44. Global Human Factor VIII Concentrate Sales Forecasted by Region (2027-2032) & (k units) Table 45. Global Human Factor VIII Concentrate Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Human Factor VIII Concentrate Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 47. North America Human Factor VIII Concentrate Sales by Country (2021-2026) & (k units) Table 48. North America Human Factor VIII Concentrate Sales by Country (2027-2032) & (k units) Table 49. Europe Human Factor VIII Concentrate Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. Europe Human Factor VIII Concentrate Sales by Country (2021-2026) & (k units) Table 51. Europe Human Factor VIII Concentrate Sales by Country (2027-2032) & (k units) Table 52. Asia Pacific Human Factor VIII Concentrate Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Asia Pacific Human Factor VIII Concentrate Sales by Country (2021-2026) & (k units) Table 54. Asia Pacific Human Factor VIII Concentrate Sales by Country (2027-2032) & (k units) Table 55. South America, Middle East and Africa Human Factor VIII Concentrate Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. South America, Middle East and Africa Human Factor VIII Concentrate Sales by Country (2021-2026) & (k units) Table 57. South America, Middle East and Africa Human Factor VIII Concentrate Sales by Country (2027-2032) & (k units) Table 58. Global Human Factor VIII Concentrate Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Human Factor VIII Concentrate Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Human Factor VIII Concentrate Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Human Factor VIII Concentrate Revenue Market Share by Region (2021-2026) Table 62. Global Human Factor VIII Concentrate Revenue Market Share by Region (2027-2032) Table 63. Shandong Taibang Biological Products Company Information Table 64. Shandong Taibang Biological Products Business Overview Table 65. Shandong Taibang Biological Products Human Factor VIII Concentrate Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Shandong Taibang Biological Products Human Factor VIII Concentrate Product Portfolio Table 67. Shandong Taibang Biological Products Recent Development Table 68. Shanghai Xinxing Medicine Company Information Table 69. Shanghai Xinxing Medicine Business Overview Table 70. Shanghai Xinxing Medicine Human Factor VIII Concentrate Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Shanghai Xinxing Medicine Human Factor VIII Concentrate Product Portfolio Table 72. Shanghai Xinxing Medicine Recent Development Table 73. Shanghai Raas Corp Company Information Table 74. Shanghai Raas Corp Business Overview Table 75. Shanghai Raas Corp Human Factor VIII Concentrate Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Shanghai Raas Corp Human Factor VIII Concentrate Product Portfolio Table 77. Shanghai Raas Corp Recent Development Table 78. Novo Nordisk A/S Company Information Table 79. Novo Nordisk A/S Business Overview Table 80. Novo Nordisk A/S Human Factor VIII Concentrate Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Novo Nordisk A/S Human Factor VIII Concentrate Product Portfolio Table 82. Novo Nordisk A/S Recent Development Table 83. Grifols Company Information Table 84. Grifols Business Overview Table 85. Grifols Human Factor VIII Concentrate Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Grifols Human Factor VIII Concentrate Product Portfolio Table 87. Grifols Recent Development Table 88. Pfizer Company Information Table 89. Pfizer Business Overview Table 90. Pfizer Human Factor VIII Concentrate Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Pfizer Human Factor VIII Concentrate Product Portfolio Table 92. Pfizer Recent Development Table 93. Hualan Biological Company Information Table 94. Hualan Biological Business Overview Table 95. Hualan Biological Human Factor VIII Concentrate Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Hualan Biological Human Factor VIII Concentrate Product Portfolio Table 97. Hualan Biological Recent Development Table 98. Bayer Company Information Table 99. Bayer Business Overview Table 100. Bayer Human Factor VIII Concentrate Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Bayer Human Factor VIII Concentrate Product Portfolio Table 102. Bayer Recent Development Table 103. SinoCell Tech Company Information Table 104. SinoCell Tech Business Overview Table 105. SinoCell Tech Human Factor VIII Concentrate Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. SinoCell Tech Human Factor VIII Concentrate Product Portfolio Table 107. SinoCell Tech Recent Development Table 108. Shire (Baxter) Company Information Table 109. Shire (Baxter) Business Overview Table 110. Shire (Baxter) Human Factor VIII Concentrate Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Shire (Baxter) Human Factor VIII Concentrate Product Portfolio Table 112. Shire (Baxter) Recent Development Table 113. Octapharma Company Information Table 114. Octapharma Business Overview Table 115. Octapharma Human Factor VIII Concentrate Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Octapharma Human Factor VIII Concentrate Product Portfolio Table 117. Octapharma Recent Development Table 118. NovoNordisk Company Information Table 119. NovoNordisk Business Overview Table 120. NovoNordisk Human Factor VIII Concentrate Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. NovoNordisk Human Factor VIII Concentrate Product Portfolio Table 122. NovoNordisk Recent Development Table 123. GC Pharma Company Information Table 124. GC Pharma Business Overview Table 125. GC Pharma Human Factor VIII Concentrate Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. GC Pharma Human Factor VIII Concentrate Product Portfolio Table 127. GC Pharma Recent Development Table 128. CSL Company Information Table 129. CSL Business Overview Table 130. CSL Human Factor VIII Concentrate Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. CSL Human Factor VIII Concentrate Product Portfolio Table 132. CSL Recent Development Table 133. Biogen Company Information Table 134. Biogen Business Overview Table 135. Biogen Human Factor VIII Concentrate Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Biogen Human Factor VIII Concentrate Product Portfolio Table 137. Biogen Recent Development Table 138. Key Raw Materials Table 139. Raw Materials Key Suppliers Table 140. Human Factor VIII Concentrate Distributors List Table 141. Human Factor VIII Concentrate Customers List Table 142. Research Programs/Design for This Report Table 143. Authors List of This Report Table 144. Secondary Sources Table 145. Primary Sources List of Figures Figure 1. Human Factor VIII Concentrate Product Image Figure 2. Global Human Factor VIII Concentrate Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Human Factor VIII Concentrate Market Size (2021-2032) & (US$ Million) Figure 4. Global Human Factor VIII Concentrate Sales (2021-2032) & (k units) Figure 5. Global Human Factor VIII Concentrate Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Human Factor VIII Concentrate Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Blood Extraction Image Figure 9. Recombine Image Figure 10. Global Human Factor VIII Concentrate Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Human Factor VIII Concentrate Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Human Factor VIII Concentrate Sales Market Share by Type (2021-2032) Figure 13. Global Human Factor VIII Concentrate Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Human Factor VIII Concentrate Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Human Factor VIII Concentrate Revenue Market Share by Type (2021-2032) Figure 16. Von Willebrand's Disease Image Figure 17. Congenital Coagulation Factor VIII Deficiency Image Figure 18. Acquired Factor VIII Deficiency Image Figure 19. Global Human Factor VIII Concentrate Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Human Factor VIII Concentrate Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Human Factor VIII Concentrate Sales Market Share by Application (2021-2032) Figure 22. Global Human Factor VIII Concentrate Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Human Factor VIII Concentrate Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Human Factor VIII Concentrate Revenue Market Share by Application (2021-2032) Figure 25. North America Human Factor VIII Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 26. North America Human Factor VIII Concentrate Sales Market Share by Country (2021-2032) Figure 27. U.S. Human Factor VIII Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 28. Canada Human Factor VIII Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 29. Mexico Human Factor VIII Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Human Factor VIII Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Human Factor VIII Concentrate Sales Market Share by Country (2021-2032) Figure 32. Germany Human Factor VIII Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 33. France Human Factor VIII Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 34. U.K. Human Factor VIII Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 35. Italy Human Factor VIII Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 36. Netherlands Human Factor VIII Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Human Factor VIII Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Human Factor VIII Concentrate Sales Market Share by Country (2021-2032) Figure 39. China Human Factor VIII Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 40. Japan Human Factor VIII Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 41. South Korea Human Factor VIII Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 42. Southeast Asia Human Factor VIII Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 43. India Human Factor VIII Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 44. Australia Human Factor VIII Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Human Factor VIII Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Human Factor VIII Concentrate Sales Market Share by Country (2021-2032) Figure 47. Brazil Human Factor VIII Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 48. South Africa Human Factor VIII Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 49. Saudi Arabia Human Factor VIII Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 50. Turkey Human Factor VIII Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 51. Argentina Human Factor VIII Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 52. UAE Human Factor VIII Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 53. Egypt Human Factor VIII Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 54. Chile Human Factor VIII Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 55. Global Human Factor VIII Concentrate Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Human Factor VIII Concentrate Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Human Factor VIII Concentrate Revenue (2021-2032) & (US$ Million) Figure 58. North America Human Factor VIII Concentrate Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Human Factor VIII Concentrate Revenue (2021-2032) & (US$ Million) Figure 60. Europe Human Factor VIII Concentrate Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Human Factor VIII Concentrate Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Human Factor VIII Concentrate Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Human Factor VIII Concentrate Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Human Factor VIII Concentrate Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Human Factor VIII Concentrate Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Human Factor VIII Concentrate Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Blood Extraction
  • Recombine
Applications
  • Von Willebrand's Disease
  • Congenital Coagulation Factor VIII Deficiency
  • Acquired Factor VIII Deficiency
Companies covered
  • Shandong Taibang Biological Products
  • Shanghai Xinxing Medicine
  • Shanghai Raas Corp
  • Novo Nordisk A/S
  • Grifols
  • Pfizer
  • Hualan Biological
  • Bayer
  • SinoCell Tech
  • Shire (Baxter)
  • Octapharma
  • NovoNordisk
  • GC Pharma
  • CSL
  • Biogen

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Human Factor VIII Concentrate Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Human Factor VIII Concentrate Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Human Factor VIII Concentrate Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Human Factor VIII Concentrate Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Human Factor VIII Concentrate Market Dynamics
  1. 2.1 Human Factor VIII Concentrate Industry Trends
  2. 2.2 Human Factor VIII Concentrate Industry Drivers
  3. 2.3 Human Factor VIII Concentrate Industry Opportunities and Challenges
  4. 2.4 Human Factor VIII Concentrate Industry Restraints
3 Human Factor VIII Concentrate Market by Manufacturers
  1. 3.1 Global Human Factor VIII Concentrate Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Human Factor VIII Concentrate Sales by Manufacturers (2021-2026)
  3. 3.3 Global Human Factor VIII Concentrate Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Human Factor VIII Concentrate Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Human Factor VIII Concentrate Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Human Factor VIII Concentrate Manufacturers, Product Type & Application
  7. 3.7 Global Human Factor VIII Concentrate Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Human Factor VIII Concentrate Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Human Factor VIII Concentrate Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Human Factor VIII Concentrate Tier 1, Tier 2, and Tier 3
4 Human Factor VIII Concentrate Market by Type
  1. 4.1 Human Factor VIII Concentrate Type Introduction
  2. 4.1.1 Blood Extraction
  3. 4.1.2 Recombine
  4. 4.2 Global Human Factor VIII Concentrate Sales by Type
  5. 4.2.1 Global Human Factor VIII Concentrate Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Human Factor VIII Concentrate Sales by Type (2021-2032)
  7. 4.2.3 Global Human Factor VIII Concentrate Sales Market Share by Type (2021-2032)
  8. 4.3 Global Human Factor VIII Concentrate Revenue by Type
  9. 4.3.1 Global Human Factor VIII Concentrate Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Human Factor VIII Concentrate Revenue by Type (2021-2032)
  11. 4.3.3 Global Human Factor VIII Concentrate Revenue Market Share by Type (2021-2032)
5 Human Factor VIII Concentrate Market by Application
  1. 5.1 Human Factor VIII Concentrate Application Introduction
  2. 5.1.1 Von Willebrand's Disease
  3. 5.1.2 Congenital Coagulation Factor VIII Deficiency
  4. 5.1.3 Acquired Factor VIII Deficiency
  5. 5.2 Global Human Factor VIII Concentrate Sales by Application
  6. 5.2.1 Global Human Factor VIII Concentrate Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Human Factor VIII Concentrate Sales by Application (2021-2032)
  8. 5.2.3 Global Human Factor VIII Concentrate Sales Market Share by Application (2021-2032)
  9. 5.3 Global Human Factor VIII Concentrate Revenue by Application
  10. 5.3.1 Global Human Factor VIII Concentrate Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Human Factor VIII Concentrate Revenue by Application (2021-2032)
  12. 5.3.3 Global Human Factor VIII Concentrate Revenue Market Share by Application (2021-2032)
6 Global Human Factor VIII Concentrate Sales by Region
  1. 6.1 Global Human Factor VIII Concentrate Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Human Factor VIII Concentrate Sales by Region (2021-2032)
  3. 6.2.1 Global Human Factor VIII Concentrate Sales by Region (2021-2026)
  4. 6.2.2 Global Human Factor VIII Concentrate Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Human Factor VIII Concentrate Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Human Factor VIII Concentrate Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Human Factor VIII Concentrate Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Human Factor VIII Concentrate Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Human Factor VIII Concentrate Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Human Factor VIII Concentrate Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Human Factor VIII Concentrate Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Human Factor VIII Concentrate Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Human Factor VIII Concentrate Revenue by Region
  1. 7.1 Global Human Factor VIII Concentrate Revenue by Region
  2. 7.1.1 Global Human Factor VIII Concentrate Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Human Factor VIII Concentrate Revenue by Region (2021-2026)
  4. 7.1.3 Global Human Factor VIII Concentrate Revenue by Region (2027-2032)
  5. 7.1.4 Global Human Factor VIII Concentrate Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Human Factor VIII Concentrate Revenue (2021-2032)
  8. 7.2.2 North America Human Factor VIII Concentrate Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Human Factor VIII Concentrate Revenue (2021-2032)
  11. 7.3.2 Europe Human Factor VIII Concentrate Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Human Factor VIII Concentrate Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Human Factor VIII Concentrate Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Human Factor VIII Concentrate Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Human Factor VIII Concentrate Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Shandong Taibang Biological Products
  2. 8.1.1 Shandong Taibang Biological Products Company Information
  3. 8.1.2 Shandong Taibang Biological Products Business Overview
  4. 8.1.3 Shandong Taibang Biological Products Human Factor VIII Concentrate Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Shandong Taibang Biological Products Human Factor VIII Concentrate Product Portfolio
  6. 8.1.5 Shandong Taibang Biological Products Recent Developments
  7. 8.2 Shanghai Xinxing Medicine
  8. 8.2.1 Shanghai Xinxing Medicine Company Information
  9. 8.2.2 Shanghai Xinxing Medicine Business Overview
  10. 8.2.3 Shanghai Xinxing Medicine Human Factor VIII Concentrate Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Shanghai Xinxing Medicine Human Factor VIII Concentrate Product Portfolio
  12. 8.2.5 Shanghai Xinxing Medicine Recent Developments
  13. 8.3 Shanghai Raas Corp
  14. 8.3.1 Shanghai Raas Corp Company Information
  15. 8.3.2 Shanghai Raas Corp Business Overview
  16. 8.3.3 Shanghai Raas Corp Human Factor VIII Concentrate Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Shanghai Raas Corp Human Factor VIII Concentrate Product Portfolio
  18. 8.3.5 Shanghai Raas Corp Recent Developments
  19. 8.4 Novo Nordisk A/S
  20. 8.4.1 Novo Nordisk A/S Company Information
  21. 8.4.2 Novo Nordisk A/S Business Overview
  22. 8.4.3 Novo Nordisk A/S Human Factor VIII Concentrate Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Novo Nordisk A/S Human Factor VIII Concentrate Product Portfolio
  24. 8.4.5 Novo Nordisk A/S Recent Developments
  25. 8.5 Grifols
  26. 8.5.1 Grifols Company Information
  27. 8.5.2 Grifols Business Overview
  28. 8.5.3 Grifols Human Factor VIII Concentrate Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Grifols Human Factor VIII Concentrate Product Portfolio
  30. 8.5.5 Grifols Recent Developments
  31. 8.6 Pfizer
  32. 8.6.1 Pfizer Company Information
  33. 8.6.2 Pfizer Business Overview
  34. 8.6.3 Pfizer Human Factor VIII Concentrate Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Pfizer Human Factor VIII Concentrate Product Portfolio
  36. 8.6.5 Pfizer Recent Developments
  37. 8.7 Hualan Biological
  38. 8.7.1 Hualan Biological Company Information
  39. 8.7.2 Hualan Biological Business Overview
  40. 8.7.3 Hualan Biological Human Factor VIII Concentrate Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Hualan Biological Human Factor VIII Concentrate Product Portfolio
  42. 8.7.5 Hualan Biological Recent Developments
  43. 8.8 Bayer
  44. 8.8.1 Bayer Company Information
  45. 8.8.2 Bayer Business Overview
  46. 8.8.3 Bayer Human Factor VIII Concentrate Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Bayer Human Factor VIII Concentrate Product Portfolio
  48. 8.8.5 Bayer Recent Developments
  49. 8.9 SinoCell Tech
  50. 8.9.1 SinoCell Tech Company Information
  51. 8.9.2 SinoCell Tech Business Overview
  52. 8.9.3 SinoCell Tech Human Factor VIII Concentrate Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 SinoCell Tech Human Factor VIII Concentrate Product Portfolio
  54. 8.9.5 SinoCell Tech Recent Developments
  55. 8.10 Shire (Baxter)
  56. 8.10.1 Shire (Baxter) Company Information
  57. 8.10.2 Shire (Baxter) Business Overview
  58. 8.10.3 Shire (Baxter) Human Factor VIII Concentrate Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Shire (Baxter) Human Factor VIII Concentrate Product Portfolio
  60. 8.10.5 Shire (Baxter) Recent Developments
  61. 8.11 Octapharma
  62. 8.11.1 Octapharma Company Information
  63. 8.11.2 Octapharma Business Overview
  64. 8.11.3 Octapharma Human Factor VIII Concentrate Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Octapharma Human Factor VIII Concentrate Product Portfolio
  66. 8.11.5 Octapharma Recent Developments
  67. 8.12 NovoNordisk
  68. 8.12.1 NovoNordisk Company Information
  69. 8.12.2 NovoNordisk Business Overview
  70. 8.12.3 NovoNordisk Human Factor VIII Concentrate Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 NovoNordisk Human Factor VIII Concentrate Product Portfolio
  72. 8.12.5 NovoNordisk Recent Developments
  73. 8.13 GC Pharma
  74. 8.13.1 GC Pharma Company Information
  75. 8.13.2 GC Pharma Business Overview
  76. 8.13.3 GC Pharma Human Factor VIII Concentrate Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 GC Pharma Human Factor VIII Concentrate Product Portfolio
  78. 8.13.5 GC Pharma Recent Developments
  79. 8.14 CSL
  80. 8.14.1 CSL Company Information
  81. 8.14.2 CSL Business Overview
  82. 8.14.3 CSL Human Factor VIII Concentrate Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 CSL Human Factor VIII Concentrate Product Portfolio
  84. 8.14.5 CSL Recent Developments
  85. 8.15 Biogen
  86. 8.15.1 Biogen Company Information
  87. 8.15.2 Biogen Business Overview
  88. 8.15.3 Biogen Human Factor VIII Concentrate Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Biogen Human Factor VIII Concentrate Product Portfolio
  90. 8.15.5 Biogen Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Human Factor VIII Concentrate Value Chain Analysis
  2. 9.1.1 Human Factor VIII Concentrate Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Human Factor VIII Concentrate Production Mode & Process
  6. 9.2 Human Factor VIII Concentrate Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Human Factor VIII Concentrate Distributors
  9. 9.2.3 Human Factor VIII Concentrate Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst